A detailed history of Global Trust Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 690 shares of AMGN stock, worth $229,390. This represents 0.09% of its overall portfolio holdings.

Number of Shares
690
Previous 790 12.66%
Holding current value
$229,390
Previous $224,000 4.02%
% of portfolio
0.09%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$262.75 - $319.31 $26,275 - $31,931
-100 Reduced 12.66%
690 $215,000
Q3 2023

Oct 12, 2023

BUY
$218.65 - $271.46 $13,337 - $16,559
61 Added 8.37%
790 $212,000
Q1 2023

Apr 14, 2023

SELL
$225.79 - $275.2 $34,545 - $42,105
-153 Reduced 17.35%
729 $176,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $34,125 - $43,360
149 Added 20.33%
882 $231,000
Q3 2022

Oct 07, 2022

SELL
$224.46 - $253.15 $6,284 - $7,088
-28 Reduced 3.68%
733 $165,000
Q2 2022

Jul 12, 2022

SELL
$230.71 - $256.74 $12,458 - $13,863
-54 Reduced 6.63%
761 $185,000
Q1 2022

Apr 12, 2022

SELL
$219.27 - $242.57 $1,754 - $1,940
-8 Reduced 0.97%
815 $197,000
Q4 2021

Jan 18, 2022

SELL
$198.88 - $227.6 $55,487 - $63,500
-279 Reduced 25.32%
823 $185,000
Q3 2021

Oct 07, 2021

SELL
$212.27 - $248.7 $50,095 - $58,693
-236 Reduced 17.64%
1,102 $234,000
Q2 2021

Jul 13, 2021

SELL
$233.58 - $259.14 $12,146 - $13,475
-52 Reduced 3.74%
1,338 $326,000
Q1 2021

Apr 14, 2021

SELL
$221.91 - $258.6 $62,356 - $72,666
-281 Reduced 16.82%
1,390 $346,000
Q4 2020

Jan 13, 2021

BUY
$216.38 - $257.67 $361,570 - $430,566
1,671 New
1,671 $384,000
Q1 2019

Apr 05, 2019

SELL
$180.87 - $203.88 $218,129 - $245,879
-1,206 Closed
0 $0
Q4 2018

Jan 11, 2019

SELL
$178.4 - $208.25 $267,778 - $312,583
-1,501 Reduced 55.45%
1,206 $235,000
Q3 2018

Oct 16, 2018

BUY
$185.29 - $208.89 $501,580 - $565,465
2,707 New
2,707 $561,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $178B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Global Trust Asset Management, LLC Portfolio

Follow Global Trust Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Trust Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Trust Asset Management, LLC with notifications on news.